Patricia C. Tsang & Guoli Chen. (2022). What's new in molecular genetic pathology 2022: Immune checkpoint inhibitor biomarkers and select solid tumors. Korean Society of Pathologists & the Korean Society for Cytopathology.
Chicago Style (17th ed.) CitationPatricia C. Tsang and Guoli Chen. What's New in Molecular Genetic Pathology 2022: Immune Checkpoint Inhibitor Biomarkers and Select Solid Tumors. Korean Society of Pathologists & the Korean Society for Cytopathology, 2022.
MLA (9th ed.) CitationPatricia C. Tsang and Guoli Chen. What's New in Molecular Genetic Pathology 2022: Immune Checkpoint Inhibitor Biomarkers and Select Solid Tumors. Korean Society of Pathologists & the Korean Society for Cytopathology, 2022.
Warning: These citations may not always be 100% accurate.